Literature DB >> 21881852

Shorter telomeres in patients with cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL).

Michele Ragno1, Luigi Pianese, Michele Pinelli, Serena Silvestri, Gabriella Cacchiò, Fabio Di Marzio, Maria Scarcella, Francesco Coretti, Fabiana Altamura, Antonella Monticelli, Imma Castaldo.   

Abstract

CADASIL is a hereditary systemic vasculopathy which affects mainly small cerebral arteries and is caused by mutations in the Notch3 gene. Misfolding of Notch3 is linked to endoplasmic reticulum stress and increased reactive oxygen species, which may result in dysfunction of endothelial cells, inflammation and ischemia. Oxidative stress and inflammation may induce a rapid telomere shortening in peripheral blood leukocytes (PBLs). The aim of this study was to assess the telomere length in PBLs from 29 patients with a genetic diagnosis of CADASIL by using a modified quantitative real-time polymerase chain reaction based assay. PBL telomere length was significantly shorter in CADASIL patients (T/S ratio = 0.17, 95% CI, 0.14-0.20) than in the controls (T/S ratio = 0.31, 95% CI, 0.27-0.35, t-test p < 0.001). Moreover, patients with functional dependence displayed shorter telomeres than those with functional independence (p = 0.039). Our data provide the first evidence that PBL telomere length is shortened in CADASIL disease, and this may be a systemic oxidative stress indicator in CADASIL patients, providing a possible biomarker of disease progression and for future therapeutic strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21881852     DOI: 10.1007/s10048-011-0298-1

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  29 in total

1.  Oxidative stress shortens telomeres.

Authors:  Thomas von Zglinicki
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

2.  Telomere shortening in T cells correlates with Alzheimer's disease status.

Authors:  L A Panossian; V R Porter; H F Valenzuela; X Zhu; Erin Reback; D Masterman; J L Cummings; R B Effros
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

3.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients.

Authors:  A Joutel; F Andreux; S Gaulis; V Domenga; M Cecillon; N Battail; N Piga; F Chapon; C Godfrain; E Tournier-Lasserve
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

4.  ROS induced DNA damage and checkpoint responses: influences on aging?

Authors:  Luis Miguel Guachalla; K Lenhard Rudolph
Journal:  Cell Cycle       Date:  2010-10-10       Impact factor: 4.534

5.  Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.

Authors:  Pawel Grabowski; Magnus Hultdin; Karin Karlsson; Gerard Tobin; Anna Aleskog; Ulf Thunberg; Anna Laurell; Christer Sundström; Richard Rosenquist; Göran Roos
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

6.  Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy.

Authors:  M L Stromillo; M T Dotti; M Battaglini; M Mortilla; S Bianchi; K Plewnia; L Pantoni; D Inzitari; A Federico; N De Stefano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-01       Impact factor: 10.154

7.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

8.  Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.

Authors:  H Vaziri; W Dragowska; R C Allsopp; T E Thomas; C B Harley; P M Lansdorp
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

9.  Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  H Chabriat; K Vahedi; M T Iba-Zizen; A Joutel; A Nibbio; T G Nagy; M O Krebs; J Julien; B Dubois; X Ducrocq
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

10.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more
  3 in total

Review 1.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

2.  Can telomere shortening in human peripheral blood leukocytes serve as a disease biomarker of Friedreich's ataxia?

Authors:  Imma Castaldo; Paola Vergara; Michele Pinelli; Alessandro Filla; Giuseppe De Michele; Sergio Cocozza; Antonella Monticelli
Journal:  Antioxid Redox Signal       Date:  2012-12-13       Impact factor: 8.401

3.  Is the oxidant/antioxidant status altered in CADASIL patients?

Authors:  Jonica Campolo; Renata De Maria; Caterina Mariotti; Chiara Tomasello; Marina Parolini; Marina Frontali; Domenico Inzitari; Raffaella Valenti; Antonio Federico; Franco Taroni; Oberdan Parodi
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.